Publications by authors named "M Vavassori"
Feline leukemia virus (FeLV) is a highly debilitating cat pathogen due to its ability to cause many pathological changes. Therefore, identifying the virus directly in bone marrow can be a highly relevant diagnostic tool even in the absence of viraemia. The aim of this study was to compare the diagnostic efficiency of immunocytochemistry (ICC) of bone marrow aspirates with enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR).
View Article and Find Full Text PDFThe COVID-19 pandemic has sparked or amplified many mental health problems. The aim of this study was to compile evidence from existing systematic reviews to provide an overall assessment of the impact of social restrictions during the COVID-19 pandemic on people affected by eating disorders (EDs). PubMed and Scopus were searched up to August 16, 2023.
View Article and Find Full Text PDFBone marrow (BM) evaluation is highly important for the diagnosis of numerous hematological alterations in animals, especially cats, given their greater propensity for hematopoietic changes associated with retrovirus infections. This study aims to describe the main aspects of the BM of cats with different hematological conditions, comparing with reference intervals established from animals without hematological alterations and also with a previously established reference interval. To do so, we evaluated full blood and BM samples from 120 cats with no abnormalities on physical examination, negative for FeLV and FIV.
View Article and Find Full Text PDFEnzyme-linked immunosorbent assay (ELISA) for viral antigen is commonly used for the diagnosis of progressive feline leukemia virus (FeLV) infection but is not able to determine the true prevalence of infection when used as the sole test. Additional testing to detect proviral DNA will identify regressive (antigen negative) FeLV infections as well as progressive infections. Therefore, this study aimed to determine the prevalence of progressive and regressive FeLV infection, outcome-associated factors, and hematologic changes.
View Article and Find Full Text PDFArticle Synopsis
- Alternating Hemiplegia of Childhood (AHC) is a serious disorder that currently lacks fully effective treatments to prevent paroxysmal attacks, despite various medications being tried.
- A study reviewed treatments in 30 AHC patients, finding that flunarizine was the most common long-term medication, effective in reducing attack frequency and intensity in a subset of patients, especially younger ones.
- The findings highlight the need for more extensive and controlled studies to explore better treatment options and understand the disease better, noting that many other therapies used had unclear effectiveness.